FTIR, Raman spectroscopy and HT-XRD in compatibility study between naproxen and excipients.
Compatibility/incompatibility
DSC
FTIR
HT-XRD
Naproxen
Raman spectroscopy
Journal
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
ISSN: 1873-3557
Titre abrégé: Spectrochim Acta A Mol Biomol Spectrosc
Pays: England
ID NLM: 9602533
Informations de publication
Date de publication:
05 Dec 2023
05 Dec 2023
Historique:
received:
22
12
2022
revised:
26
05
2023
accepted:
18
06
2023
medline:
7
9
2023
pubmed:
25
6
2023
entrez:
24
6
2023
Statut:
ppublish
Résumé
Detection of incompatibility between an active pharmaceutical ingredient (API) and excipients, including the selection of the most biopharmaceutical advantageous excipients is extremely important in the pre-formulation process of developing a solid dosage form technology. Therefore, having fast and reliable methods for identifying incompatibility is fundamental in pharmaceutical technology. For this purpose, combined Fourier transform infrared (FTIR) and Raman spectroscopy as well as high-temperature X-ray diffraction (HT-XRD) were used as a new approach for incompatibility detection, whereas differential scanning calorimetry (DSC) was applied as a reference method. In addition, to facilitate the interpretation of FTIR and Raman data, a multivariate analysis was used - hierarchical cluster analysis (HCA). The tests were carried out in mixtures of naproxen (NPX) with eight selected polymer excipients, mixed at a 1:1 ratio. The results of spectroscopic analyses have shown the physical incompatibility of NPX with methylcellulose (MC), hydroxypropylmethylcellulose (HPMC), hydroxyethylcellulose (HEC), sodium starch glycolate (SSG) and sodium carboxymethylcellulose (CMC). HT-XRD studies performed when these mixtures were heated to 156 °C and then cooled to 25 °C showed a decrease in naproxen crystallinity in these mixtures. Furthermore, the results obtained with spectroscopic methods were confirmed by DSC tests and an intrinsic dissolution rate study.
Identifiants
pubmed: 37354860
pii: S1386-1425(23)00733-3
doi: 10.1016/j.saa.2023.123048
pii:
doi:
Substances chimiques
Excipients
0
Naproxen
57Y76R9ATQ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
123048Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.